Last checked at 16 Aug 2021 09:20
Ireland set to halt further orders of AstraZeneca and J&J vaccines
Ireland set to halt further orders of AstraZeneca and J&J vaccines
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News8
AZN Share
Chat4
AZN Share
Trades14,250
AZN
Live RNS1
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
11,982.00
Bid:
11,980.00
Ask:
11,984.00
Change:
630.00 (5.55%)
Spread:
4.00 (0.033%)
Open:
11,890.00
High:
12,086.00
Low:
11,790.00
Prev. Close:
11,352.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.15 Aug 2021 19:45
Serbia authorises third shot of COVID-19 vaccine, minister says
BELGRADE, Aug 15 (Reuters) - The Serbian health authorities authorised a third dose of COVID-19 vaccines for people with compromised immune systems, health workers and anyone vaccinated at least six months ago, country's labour minister said on S...
Read more15 Aug 2021 17:08
Sunday newspaper round-up: Meggitt, GlaxoSmithKline, Luxury goods
(Sharecast News) - Ministers must be prepared to block a takeover of Meggitt if any bidder tries to buy it without giving binding commitments on investment and jobs, the FTSE 250 aerospace and defence manufacturer's chairman warned this weekend. Sir Nigel Rudd said that while "clearly, price is important", any new owner would need to give Meggitt and the government undertakings, including to keep the company's headquarters in Coventry and maintain R&D spending. - Sunday Times
Read more13 Aug 2021 11:54
UPDATE 1-FOCUS-Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market
(Updates with FDA approval of boosters for immunocompromised in para 4)By Michael ErmanNEW YORK, Aug 13 (Reuters) - Drugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market th...
Read more13 Aug 2021 11:00
FOCUS-Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market
By Michael ErmanNEW YORK, Aug 13 (Reuters) - Drugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for year...
Read more13 Aug 2021 09:07
UPDATE 1-S.Korea signs new Pfizer vaccine deal; asks people to cut travel
(Recasts with Pfizer vaccine deal)By Sangmi ChaSEOUL, Aug 13 (Reuters) - South Korea on Friday signed a deal to buy 30 million doses of Pfizer's COVID-19 vaccine for 2022, and the government urged people to cut holiday travel amid a worsening four...
Read more12 Aug 2021 18:03
FDA working to allow boosters for vulnerable people-CDC director
Aug 12 (Reuters) - The U.S. Food and Drug Administration is working with vaccine makers Pfizer Inc and Moderna Inc to allow certain vulnerable people to receive a third booster shot of their COVID-19 vaccines to improve their immune response, the...
Read more12 Aug 2021 13:56
IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca
IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca
Read more12 Aug 2021 12:29
Cambodia starts vaccine booster drive to shore up COVID-19 defence
By Chantha LachPHNOM PENH, Aug 12 (Reuters) - Cambodia started offering coronavirus vaccine booster shots on Thursday in a renewed public health drive after managing to inoculate more than half of its population.One of Asia's poorest countries, Ca...
Read more12 Aug 2021 12:11
JP Morgan restarts AstraZeneca at overweight, sees re-rating opportunity
(Sharecast News) - Analysts at JP Morgan resumed their coverage of AstraZeneca at 'overweight', telling clients they saw a "re-rating opportunity".
Read more12 Aug 2021 12:09
Thursday broker round-up
(Sharecast News) - Hill&Smith: Berenberg keeps at buy and raises target price from 1,775.0p to 1,995.0p.
Read more12 Aug 2021 09:41
LONDON BROKER RATINGS: Bank of America resumes Flutter At Buy
LONDON BROKER RATINGS: Bank of America resumes Flutter At Buy
Read more12 Aug 2021 08:18
LONDON BRIEFING: UK economy continues post-pandemic rebound
LONDON BRIEFING: UK economy continues post-pandemic rebound
Read more11 Aug 2021 22:00
Age restrictions on AstraZeneca shot have ended reports of rare clots -UK scientists
LONDON, Aug 11 (Reuters) - No new cases of a rare and severe blood clots following vaccination with AstraZeneca's COVID shot have been reported in Britain in recent weeks after a decision to restrict its use in under-40s, British scientists said ...
Read more11 Aug 2021 15:10
UPDATE 2-EU looking into new possible side-effects of mRNA COVID-19 shots
* Skin rash, two kidney disorders being studied by EMA* Requested more data from Pfizer, Moderna* Has not recommended label changes (Adds detail throughout)By Pushkala AripakaAug 11 (Reuters) - Three new conditions reported by a small number of peo...
Read more